Neoadjuvant Ql1209 (A Pertuzumab Biosimilar) Compared With Pertuzumab Plus Trastuzumab And Docetaxel In Early Or Locally Advanced, Her2-Positive, Er(-)/Pr(-) Breast Cancer: A Multicenter, Randomized, Double-Blind, Equivalence, Phase III Study
Ql1209;Docetaxel ;Pertuzumab;Trastuzumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Neoadjuvant Ql1209 (A Pertuzumab Biosimilar) Compared With Pertuzumab Plus Trastuzumab And Docetaxel In Early Or Locally Advanced, Her2-Positive, Er(-)/Pr(-) Breast Cancer: A Multicenter, Randomized, Double-Blind, Equivalence, Phase III Study ### Output: Ql1209;Docetaxel ;Pertuzumab;Trastuzumab